Skip to main content

Table 1 Patient demographics and baseline characteristics (N = 17)

From: An 8 week open-label interventional multicenter study to explore the lung clearance index as endpoint for clinical trials in cystic fibrosis patients ≥8 years of age, chronically infected with Pseudomonas aeruginosa

Age, years26.4 (9.99)
Men, n (%)11 (64.7)
Height, cm171.12 (12.8)
Weight, kg62.6 (12.9)
Waist circumference, cm85.1 (22.6)
BMI, kg/m221.1 (2.5)
LCI17.99 (4.7)
FEV(%)76.96 (18.6)
  1. Data are expressed as mean (SD) unless indicated otherwise
  2. BMI body mass index, FEV1 forced expiratory volume in 1 second, LCI lung clearance index, SD standard deviation